1. Heaton R, Grant I, Butters N, White DA, Kirson D, Atkinson HJ, McCuthchan JA, Taylor M, Kelly MD, Ellis RJ, Wolfson T, Velin RA, Marcotte TD, Hesselink JR, Jernigan TL, Chandler J, Wallace M, Abramason I. The HNRC 500-Neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc. 1995;1(231):251.
2. Heaton RK, Clifford DB, Franklin DR Jr., Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, AbramsonI, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, the CHARTER Group HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Clin Infect Dis. 2015;60(3):473–80. doi:
10.1093/cid/ciu862
. Epub 2014.
3. Reger MA, Martin DJ, Sherwood LC, Strauss G. The relationship between viral load and neuropsychological functioning in HIV-1 infection. Arch Clin Neuropsychol. 2005;20:137–43.
4. Garrido JM, Alvarez M, Lopez MA. Neuropsychological impairment and gender differences in HIV-1 infection. Psychiatry Clin Neurosci. 2008;62:494–502.
5. Durvasula RS, Norman, LR, Malow R Current perspectioves on neuropsychology of HIV’ 177–190 in HIV/AIDS global frontiers in prevention/intervention. Pope C, White CRT, Malow R (eds). New York: Tylor and Francis; (2009)